AIA Group Ltd Makes New $4.40 Million Investment in CME Group Inc. $CME

CME Group logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • AIA Group acquired a new stake in CME Group, purchasing 16,809 shares worth about $4.4 million during the third quarter. Institutional investors collectively own 87.75% of the stock.
  • CME Group reported quarterly earnings of $3.02 per share, above the $2.99 consensus estimate, while revenue rose 10.6% year over year to $1.74 billion.
  • Record crypto trading activity and market-data revenue—reported at $243 million for the quarter—could support transaction and recurring revenue. Analysts’ average rating is “Hold,” with an average price target of $314.44.
  • Five stocks to consider instead of CME Group.

AIA Group Ltd purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 16,809 shares of the financial services provider's stock, valued at approximately $4,404,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Third View Private Wealth LLC boosted its holdings in shares of CME Group by 43.8% in the third quarter. Third View Private Wealth LLC now owns 1,432 shares of the financial services provider's stock worth $375,000 after buying an additional 436 shares during the last quarter. Provenance Wealth Advisors LLC bought a new stake in CME Group during the third quarter valued at approximately $450,000. First Nebraska Trust Co bought a new stake in CME Group during the third quarter valued at approximately $517,000. Stiles Financial Services Inc increased its holdings in CME Group by 6.1% during the third quarter. Stiles Financial Services Inc now owns 15,237 shares of the financial services provider's stock valued at $3,992,000 after buying an additional 870 shares during the last quarter. Finally, CrossGen Wealth LLC increased its holdings in CME Group by 5.0% during the third quarter. CrossGen Wealth LLC now owns 7,053 shares of the financial services provider's stock valued at $1,848,000 after buying an additional 337 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

  • Positive Sentiment: October weekend trading in crypto reportedly reached a record $1.3 billion on CME, while coverage also highlights record trading volumes. Sustained activity could lift transaction-related revenue. Weekend crypto trading article Record trading volumes article
  • Positive Sentiment: CME Group’s market-data revenue reached a record $243 million last quarter, adding a recurring revenue source alongside trading fees. Market-data revenue article
  • Neutral Sentiment: The CFTC’s approval of stock perpetual futures for U.S. registered exchanges could expand the futures market, but the report does not establish how much CME Group may benefit. CFTC stock perpetual futures article
  • Negative Sentiment: Two insiders sold shares on Nov. 2: Julie Winkler sold 10,079 shares, reducing her position by about 32%, and director Howard Siegel sold 2,000 shares, cutting his holdings by about 9%. Such sales may weigh on sentiment, although both retained shares. Insider sales report

Insider Activity

In other news, Director Martin Gepsman sold 400 shares of the business's stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $302.50, for a total value of $121,000.00. Following the transaction, the director owned 25,244 shares of the company's stock, valued at approximately $7,636,310. The trade was a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Julie Winkler sold 10,079 shares of the company's stock in a transaction on Monday, November 2nd. The stock was sold at an average price of $305.15, for a total transaction of $3,075,606.85. Following the transaction, the insider owned 21,482 shares of the company's stock, valued at approximately $6,555,232.30. This represents a 31.93% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 32,979 shares of company stock valued at $9,552,762. Company insiders own 0.30% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Wall Street Zen upgraded shares of CME Group from a "sell" rating to a "hold" rating in a research report on Saturday, October 31st. Barclays boosted their price objective on shares of CME Group from $281.00 to $321.00 and gave the company an "equal weight" rating in a research report on Thursday, October 22nd. UBS Group upped their price objective on CME Group from $270.00 to $310.00 and gave the stock a "neutral" rating in a research note on Thursday, October 22nd. Morgan Stanley raised their target price on CME Group from $337.00 to $359.00 and gave the stock an "overweight" rating in a report on Thursday, October 22nd. Finally, CLSA set a $367.00 target price on CME Group in a research report on Thursday, October 22nd. Ten equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, CME Group currently has an average rating of "Hold" and an average price target of $314.44.

Get Our Latest Stock Analysis on CME Group

CME Group Trading Up 1.4%

Shares of CME Group stock opened at $308.27 on Thursday. The company has a market capitalization of $110.34 billion, a P/E ratio of 25.29, a P/E/G ratio of 3.71 and a beta of 0.15. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a fifty day moving average of $282.08 and a 200 day moving average of $280.52. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, beating analysts' consensus estimates of $2.99 by $0.03. CME Group had a return on equity of 16.23% and a net margin of 63.33%. The business had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.71 billion. During the same period last year, the firm earned $2.68 earnings per share. The business's quarterly revenue was up 10.6% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc. will post 12.34 earnings per share for the current fiscal year.

CME Group Company Profile

(Free Report)

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group's exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines